The company is commercializing technology developed at Dartmouth and Stanford universities, hoping that its technology will reduce the size and complication rates of implantable devices.
Resonant Link is ready to move towards commercialization of its wireless charging technologies, setting its sights on medical device integration, the company announced on 9 June.
Resonant Link was founded in 2017 as a spin-out from Dartmouth and Stanford universities, Resonant Link set out with the...
Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.
The US FDA has announced classifications for five device types, including four diagnostics as well as a hand cream to protect healthcare workers exposed to radiation. Two of the products are newborn screening tests.
Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.
